Treatment-resistant tinea corporis, a potential public health issue
- PMID: 33428216
- DOI: 10.1111/bjd.19420
Treatment-resistant tinea corporis, a potential public health issue
Similar articles
-
Superficial fungal infections.Pediatr Rev. 2012 Apr;33(4):e22-37. doi: 10.1542/pir.33-4-e22. Pediatr Rev. 2012. PMID: 22474120 Review.
-
Topical treatment of common superficial tinea infections.Am Fam Physician. 2002 May 15;65(10):2095-102. Am Fam Physician. 2002. PMID: 12046779 Review.
-
Case of tinea corporis due to terbinafine-resistant Trichophyton interdigitale.J Dermatol. 2020 Apr;47(4):e104-e105. doi: 10.1111/1346-8138.15243. Epub 2020 Jan 28. J Dermatol. 2020. PMID: 31994232 No abstract available.
-
Psoriasiform id reaction in tinea corporis.Mycoses. 1996 Jul-Aug;39(7-8):307-8. doi: 10.1111/j.1439-0507.1996.tb00144.x. Mycoses. 1996. PMID: 9009651
-
Tinea corporis in a mixed martial arts fighter.CMAJ. 2013 Jul 9;185(10):897. doi: 10.1503/cmaj.120813. Epub 2012 Oct 29. CMAJ. 2013. PMID: 23109614 Free PMC article. No abstract available.
Cited by
-
Time to Think Antifungal Resistance Increased Antifungal Resistance Exacerbates the Burden of Fungal Infections Including Resistant Dermatomycoses.Pathog Immun. 2024 Mar 5;8(2):158-176. doi: 10.20411/pai.v8i2.656. eCollection 2023. Pathog Immun. 2024. PMID: 38486922 Free PMC article.
-
The Rise of Antifungal-Resistant Dermatophyte Infections: What Dermatologists Need to Know.Cutis. 2025 May;115(5):151-154. doi: 10.12788/cutis.1211. Cutis. 2025. PMID: 40591859 Free PMC article. Review.
-
Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical Trial.JAMA Dermatol. 2022 Sep 14;158(11):1269-78. doi: 10.1001/jamadermatol.2022.3745. Online ahead of print. JAMA Dermatol. 2022. PMID: 36103158 Free PMC article.
-
Epidemiology of dermatomycoses and onychomycoses in Ireland (2001-2020): A single-institution review.Mycoses. 2022 Jul;65(7):770-779. doi: 10.1111/myc.13473. Mycoses. 2022. PMID: 35598177 Free PMC article.
-
Scratching the surface: The rise of antifungal-resistant dermatophytes.Clin Microbiol Newsl. 2025 Jun;51:26-30. doi: 10.1016/j.clinmicnews.2025.04.003. Clin Microbiol Newsl. 2025. PMID: 40520827 Free PMC article.
References
-
- Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Available at: https://clsi.org/standards/products/microbiology/documents/m38/ (last accessed 31 July 2020).
-
- Dogra S, Uprety S. The menace of chronic and recurrent dermatophytosis in India: is the problem deeper than we perceive? Indian Dermatol Online J 2016; 7:73–6.
-
- Mukherjee PK, Leidich SD, Isham N et al. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother 2003; 47:82–6.
-
- Digby SS, Hald M, Arendrup MC et al. Darier disease complicated by terbinafine‐resistant Trichophyton rubrum: a case report. Acta Derm Venereol 2017; 97:139–40.
-
- Ghelardi E, Celandroni F, Gueye SA et al. Potential of ergosterol synthesis inhibitors to cause resistance or cross‐resistance in Trichophyton rubrum. Antimicrob Agents Chemother 2014; 58:2825–9.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical